ASAP3 and central nervous system cancer: These results of the GEPIA database showed that higher ASAP3 expression was associated with OS and DFS in gliomas (n = 338, OS: Hazard Ratio (HR) = 1.4, P = 0.018; n = 338, DFS: HR = 1.5, P = 0.0023).